Chairman, CEO and President of Becton, Dickinson And Co (30-Year Financial, Insider Trades) Vincent A Forlenza (insider trades) sold 28,514 shares of BDX on 01/28/2020 at an average price of $280.96 a share. The total sale was $8 million.
Becton, Dickinson and Co is a healthcare company. It manufacture and sales medical supplies, devices, laboratory equipment and diagnostic products. It operates in two segments BD Medical and BD Life Sciences. Becton, Dickinson and Co has a market cap of $76.5 billion; its shares were traded at around $282.26 with a P/E ratio of 72.38 and P/S ratio of 4.47. The dividend yield of Becton, Dickinson and Co stocks is 1.10%. Becton, Dickinson and Co had annual average EBITDA growth of 5.30% over the past ten years. GuruFocus rated Becton, Dickinson and Co the business predictability rank of 3-star. GuruFocus has detected 2 severe warning signs with Becton, Dickinson and Co. .
CEO Recent Trades:
- Chairman, CEO and President Vincent A Forlenza sold 28,514 shares of BDX stock on 01/28/2020 at the average price of $280.96. The price of the stock has increased by 0.46% since.
- Chairman, CEO and President Vincent A Forlenza sold 39,007 shares of BDX stock on 01/27/2020 at the average price of $280.09. The price of the stock has increased by 0.77% since.
- Chairman, CEO and President Vincent A Forlenza sold 33,535 shares of BDX stock on 01/10/2020 at the average price of $275.17. The price of the stock has increased by 2.58% since.
- Chairman, CEO and President Vincent A Forlenza sold 33,365 shares of BDX stock on 01/02/2020 at the average price of $271.28. The price of the stock has increased by 4.05% since.
For the complete insider trading history of BDX, click here
.
